Nanoparticle-Mediated Delivery Market, Global Outlook and Forecast 2022-2028

July 2022 | 104 pages | ID: ND4CBB3E2623EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Nanoparticle-Mediated Delivery in Global, including the following market information:

Global Nanoparticle-Mediated Delivery Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Nanoparticle-Mediated Delivery market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Biological Origin Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Nanoparticle-Mediated Delivery include AbbVie, BlueWillow Biologics, NovaSOL, Camurus, Ceramisphere, Celgene, CytImmune, Cristal Therapeutics, EnColl and Lena Nanoceutics Ltd., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Nanoparticle-Mediated Delivery companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Nanoparticle-Mediated Delivery Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Nanoparticle-Mediated Delivery Market Segment Percentages, by Type, 2021 (%)

• Biological Origin
• Non-Biological Origin

Global Nanoparticle-Mediated Delivery Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Nanoparticle-Mediated Delivery Market Segment Percentages, by Application, 2021 (%)

• Drug Delivery
• Gene Delivery

Global Nanoparticle-Mediated Delivery Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Nanoparticle-Mediated Delivery Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Nanoparticle-Mediated Delivery revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Nanoparticle-Mediated Delivery revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AbbVie
• BlueWillow Biologics
• NovaSOL
• Camurus
• Ceramisphere
• Celgene, CytImmune
• Cristal Therapeutics
• EnColl
• Lena Nanoceutics Ltd.
• EyePoint Pharmaceuticals
• Nanobiotix
• NanoCarrier
• Nanospectra
• NanOlogy
• Selecta Biosciences
• Parvus Therapeutics
• Starpharma
• Tarveda Therapeutics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Nanoparticle-Mediated Delivery Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Nanoparticle-Mediated Delivery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL NANOPARTICLE-MEDIATED DELIVERY OVERALL MARKET SIZE

2.1 Global Nanoparticle-Mediated Delivery Market Size: 2021 VS 2028
2.2 Global Nanoparticle-Mediated Delivery Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Nanoparticle-Mediated Delivery Players in Global Market
3.2 Top Global Nanoparticle-Mediated Delivery Companies Ranked by Revenue
3.3 Global Nanoparticle-Mediated Delivery Revenue by Companies
3.4 Top 3 and Top 5 Nanoparticle-Mediated Delivery Companies in Global Market, by Revenue in 2021
3.5 Global Companies Nanoparticle-Mediated Delivery Product Type
3.6 Tier 1, Tier 2 and Tier 3 Nanoparticle-Mediated Delivery Players in Global Market
  3.6.1 List of Global Tier 1 Nanoparticle-Mediated Delivery Companies
  3.6.2 List of Global Tier 2 and Tier 3 Nanoparticle-Mediated Delivery Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Nanoparticle-Mediated Delivery Market Size Markets, 2021 & 2028
  4.1.2 Biological Origin
  4.1.3 Non-Biological Origin
4.2 By Type - Global Nanoparticle-Mediated Delivery Revenue & Forecasts
  4.2.1 By Type - Global Nanoparticle-Mediated Delivery Revenue, 2017-2022
  4.2.2 By Type - Global Nanoparticle-Mediated Delivery Revenue, 2023-2028
  4.2.3 By Type - Global Nanoparticle-Mediated Delivery Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Nanoparticle-Mediated Delivery Market Size, 2021 & 2028
  5.1.2 Drug Delivery
  5.1.3 Gene Delivery
5.2 By Application - Global Nanoparticle-Mediated Delivery Revenue & Forecasts
  5.2.1 By Application - Global Nanoparticle-Mediated Delivery Revenue, 2017-2022
  5.2.2 By Application - Global Nanoparticle-Mediated Delivery Revenue, 2023-2028
  5.2.3 By Application - Global Nanoparticle-Mediated Delivery Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Nanoparticle-Mediated Delivery Market Size, 2021 & 2028
6.2 By Region - Global Nanoparticle-Mediated Delivery Revenue & Forecasts
  6.2.1 By Region - Global Nanoparticle-Mediated Delivery Revenue, 2017-2022
  6.2.2 By Region - Global Nanoparticle-Mediated Delivery Revenue, 2023-2028
  6.2.3 By Region - Global Nanoparticle-Mediated Delivery Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Nanoparticle-Mediated Delivery Revenue, 2017-2028
  6.3.2 US Nanoparticle-Mediated Delivery Market Size, 2017-2028
  6.3.3 Canada Nanoparticle-Mediated Delivery Market Size, 2017-2028
  6.3.4 Mexico Nanoparticle-Mediated Delivery Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Nanoparticle-Mediated Delivery Revenue, 2017-2028
  6.4.2 Germany Nanoparticle-Mediated Delivery Market Size, 2017-2028
  6.4.3 France Nanoparticle-Mediated Delivery Market Size, 2017-2028
  6.4.4 U.K. Nanoparticle-Mediated Delivery Market Size, 2017-2028
  6.4.5 Italy Nanoparticle-Mediated Delivery Market Size, 2017-2028
  6.4.6 Russia Nanoparticle-Mediated Delivery Market Size, 2017-2028
  6.4.7 Nordic Countries Nanoparticle-Mediated Delivery Market Size, 2017-2028
  6.4.8 Benelux Nanoparticle-Mediated Delivery Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Nanoparticle-Mediated Delivery Revenue, 2017-2028
  6.5.2 China Nanoparticle-Mediated Delivery Market Size, 2017-2028
  6.5.3 Japan Nanoparticle-Mediated Delivery Market Size, 2017-2028
  6.5.4 South Korea Nanoparticle-Mediated Delivery Market Size, 2017-2028
  6.5.5 Southeast Asia Nanoparticle-Mediated Delivery Market Size, 2017-2028
  6.5.6 India Nanoparticle-Mediated Delivery Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Nanoparticle-Mediated Delivery Revenue, 2017-2028
  6.6.2 Brazil Nanoparticle-Mediated Delivery Market Size, 2017-2028
  6.6.3 Argentina Nanoparticle-Mediated Delivery Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Nanoparticle-Mediated Delivery Revenue, 2017-2028
  6.7.2 Turkey Nanoparticle-Mediated Delivery Market Size, 2017-2028
  6.7.3 Israel Nanoparticle-Mediated Delivery Market Size, 2017-2028
  6.7.4 Saudi Arabia Nanoparticle-Mediated Delivery Market Size, 2017-2028
  6.7.5 UAE Nanoparticle-Mediated Delivery Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 AbbVie
  7.1.1 AbbVie Corporate Summary
  7.1.2 AbbVie Business Overview
  7.1.3 AbbVie Nanoparticle-Mediated Delivery Major Product Offerings
  7.1.4 AbbVie Nanoparticle-Mediated Delivery Revenue in Global Market (2017-2022)
  7.1.5 AbbVie Key News
7.2 BlueWillow Biologics
  7.2.1 BlueWillow Biologics Corporate Summary
  7.2.2 BlueWillow Biologics Business Overview
  7.2.3 BlueWillow Biologics Nanoparticle-Mediated Delivery Major Product Offerings
  7.2.4 BlueWillow Biologics Nanoparticle-Mediated Delivery Revenue in Global Market (2017-2022)
  7.2.5 BlueWillow Biologics Key News
7.3 NovaSOL
  7.3.1 NovaSOL Corporate Summary
  7.3.2 NovaSOL Business Overview
  7.3.3 NovaSOL Nanoparticle-Mediated Delivery Major Product Offerings
  7.3.4 NovaSOL Nanoparticle-Mediated Delivery Revenue in Global Market (2017-2022)
  7.3.5 NovaSOL Key News
7.4 Camurus
  7.4.1 Camurus Corporate Summary
  7.4.2 Camurus Business Overview
  7.4.3 Camurus Nanoparticle-Mediated Delivery Major Product Offerings
  7.4.4 Camurus Nanoparticle-Mediated Delivery Revenue in Global Market (2017-2022)
  7.4.5 Camurus Key News
7.5 Ceramisphere
  7.5.1 Ceramisphere Corporate Summary
  7.5.2 Ceramisphere Business Overview
  7.5.3 Ceramisphere Nanoparticle-Mediated Delivery Major Product Offerings
  7.5.4 Ceramisphere Nanoparticle-Mediated Delivery Revenue in Global Market (2017-2022)
  7.5.5 Ceramisphere Key News
7.6 Celgene, CytImmune
  7.6.1 Celgene, CytImmune Corporate Summary
  7.6.2 Celgene, CytImmune Business Overview
  7.6.3 Celgene, CytImmune Nanoparticle-Mediated Delivery Major Product Offerings
  7.6.4 Celgene, CytImmune Nanoparticle-Mediated Delivery Revenue in Global Market (2017-2022)
  7.6.5 Celgene, CytImmune Key News
7.7 Cristal Therapeutics
  7.7.1 Cristal Therapeutics Corporate Summary
  7.7.2 Cristal Therapeutics Business Overview
  7.7.3 Cristal Therapeutics Nanoparticle-Mediated Delivery Major Product Offerings
  7.7.4 Cristal Therapeutics Nanoparticle-Mediated Delivery Revenue in Global Market (2017-2022)
  7.7.5 Cristal Therapeutics Key News
7.8 EnColl
  7.8.1 EnColl Corporate Summary
  7.8.2 EnColl Business Overview
  7.8.3 EnColl Nanoparticle-Mediated Delivery Major Product Offerings
  7.8.4 EnColl Nanoparticle-Mediated Delivery Revenue in Global Market (2017-2022)
  7.8.5 EnColl Key News
7.9 Lena Nanoceutics Ltd.
  7.9.1 Lena Nanoceutics Ltd. Corporate Summary
  7.9.2 Lena Nanoceutics Ltd. Business Overview
  7.9.3 Lena Nanoceutics Ltd. Nanoparticle-Mediated Delivery Major Product Offerings
  7.9.4 Lena Nanoceutics Ltd. Nanoparticle-Mediated Delivery Revenue in Global Market (2017-2022)
  7.9.5 Lena Nanoceutics Ltd. Key News
7.10 EyePoint Pharmaceuticals
  7.10.1 EyePoint Pharmaceuticals Corporate Summary
  7.10.2 EyePoint Pharmaceuticals Business Overview
  7.10.3 EyePoint Pharmaceuticals Nanoparticle-Mediated Delivery Major Product Offerings
  7.10.4 EyePoint Pharmaceuticals Nanoparticle-Mediated Delivery Revenue in Global Market (2017-2022)
  7.10.5 EyePoint Pharmaceuticals Key News
7.11 Nanobiotix
  7.11.1 Nanobiotix Corporate Summary
  7.11.2 Nanobiotix Business Overview
  7.11.3 Nanobiotix Nanoparticle-Mediated Delivery Major Product Offerings
  7.11.4 Nanobiotix Nanoparticle-Mediated Delivery Revenue in Global Market (2017-2022)
  7.11.5 Nanobiotix Key News
7.12 NanoCarrier
  7.12.1 NanoCarrier Corporate Summary
  7.12.2 NanoCarrier Business Overview
  7.12.3 NanoCarrier Nanoparticle-Mediated Delivery Major Product Offerings
  7.12.4 NanoCarrier Nanoparticle-Mediated Delivery Revenue in Global Market (2017-2022)
  7.12.5 NanoCarrier Key News
7.13 Nanospectra
  7.13.1 Nanospectra Corporate Summary
  7.13.2 Nanospectra Business Overview
  7.13.3 Nanospectra Nanoparticle-Mediated Delivery Major Product Offerings
  7.13.4 Nanospectra Nanoparticle-Mediated Delivery Revenue in Global Market (2017-2022)
  7.13.5 Nanospectra Key News
7.14 NanOlogy
  7.14.1 NanOlogy Corporate Summary
  7.14.2 NanOlogy Business Overview
  7.14.3 NanOlogy Nanoparticle-Mediated Delivery Major Product Offerings
  7.14.4 NanOlogy Nanoparticle-Mediated Delivery Revenue in Global Market (2017-2022)
  7.14.5 NanOlogy Key News
7.15 Selecta Biosciences
  7.15.1 Selecta Biosciences Corporate Summary
  7.15.2 Selecta Biosciences Business Overview
  7.15.3 Selecta Biosciences Nanoparticle-Mediated Delivery Major Product Offerings
  7.15.4 Selecta Biosciences Nanoparticle-Mediated Delivery Revenue in Global Market (2017-2022)
  7.15.5 Selecta Biosciences Key News
7.16 Parvus Therapeutics
  7.16.1 Parvus Therapeutics Corporate Summary
  7.16.2 Parvus Therapeutics Business Overview
  7.16.3 Parvus Therapeutics Nanoparticle-Mediated Delivery Major Product Offerings
  7.16.4 Parvus Therapeutics Nanoparticle-Mediated Delivery Revenue in Global Market (2017-2022)
  7.16.5 Parvus Therapeutics Key News
7.17 Starpharma
  7.17.1 Starpharma Corporate Summary
  7.17.2 Starpharma Business Overview
  7.17.3 Starpharma Nanoparticle-Mediated Delivery Major Product Offerings
  7.17.4 Starpharma Nanoparticle-Mediated Delivery Revenue in Global Market (2017-2022)
  7.17.5 Starpharma Key News
7.18 Tarveda Therapeutics
  7.18.1 Tarveda Therapeutics Corporate Summary
  7.18.2 Tarveda Therapeutics Business Overview
  7.18.3 Tarveda Therapeutics Nanoparticle-Mediated Delivery Major Product Offerings
  7.18.4 Tarveda Therapeutics Nanoparticle-Mediated Delivery Revenue in Global Market (2017-2022)
  7.18.5 Tarveda Therapeutics Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Nanoparticle-Mediated Delivery Market Opportunities & Trends in Global Market
Table 2. Nanoparticle-Mediated Delivery Market Drivers in Global Market
Table 3. Nanoparticle-Mediated Delivery Market Restraints in Global Market
Table 4. Key Players of Nanoparticle-Mediated Delivery in Global Market
Table 5. Top Nanoparticle-Mediated Delivery Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Nanoparticle-Mediated Delivery Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Nanoparticle-Mediated Delivery Revenue Share by Companies, 2017-2022
Table 8. Global Companies Nanoparticle-Mediated Delivery Product Type
Table 9. List of Global Tier 1 Nanoparticle-Mediated Delivery Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Nanoparticle-Mediated Delivery Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Nanoparticle-Mediated Delivery Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Nanoparticle-Mediated Delivery Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Nanoparticle-Mediated Delivery Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Nanoparticle-Mediated Delivery Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Nanoparticle-Mediated Delivery Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Nanoparticle-Mediated Delivery Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Nanoparticle-Mediated Delivery Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Nanoparticle-Mediated Delivery Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Nanoparticle-Mediated Delivery Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Nanoparticle-Mediated Delivery Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Nanoparticle-Mediated Delivery Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Nanoparticle-Mediated Delivery Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Nanoparticle-Mediated Delivery Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Nanoparticle-Mediated Delivery Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Nanoparticle-Mediated Delivery Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Nanoparticle-Mediated Delivery Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Nanoparticle-Mediated Delivery Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Nanoparticle-Mediated Delivery Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Nanoparticle-Mediated Delivery Revenue, (US$, Mn), 2023-2028
Table 30. AbbVie Corporate Summary
Table 31. AbbVie Nanoparticle-Mediated Delivery Product Offerings
Table 32. AbbVie Nanoparticle-Mediated Delivery Revenue (US$, Mn), (2017-2022)
Table 33. BlueWillow Biologics Corporate Summary
Table 34. BlueWillow Biologics Nanoparticle-Mediated Delivery Product Offerings
Table 35. BlueWillow Biologics Nanoparticle-Mediated Delivery Revenue (US$, Mn), (2017-2022)
Table 36. NovaSOL Corporate Summary
Table 37. NovaSOL Nanoparticle-Mediated Delivery Product Offerings
Table 38. NovaSOL Nanoparticle-Mediated Delivery Revenue (US$, Mn), (2017-2022)
Table 39. Camurus Corporate Summary
Table 40. Camurus Nanoparticle-Mediated Delivery Product Offerings
Table 41. Camurus Nanoparticle-Mediated Delivery Revenue (US$, Mn), (2017-2022)
Table 42. Ceramisphere Corporate Summary
Table 43. Ceramisphere Nanoparticle-Mediated Delivery Product Offerings
Table 44. Ceramisphere Nanoparticle-Mediated Delivery Revenue (US$, Mn), (2017-2022)
Table 45. Celgene, CytImmune Corporate Summary
Table 46. Celgene, CytImmune Nanoparticle-Mediated Delivery Product Offerings
Table 47. Celgene, CytImmune Nanoparticle-Mediated Delivery Revenue (US$, Mn), (2017-2022)
Table 48. Cristal Therapeutics Corporate Summary
Table 49. Cristal Therapeutics Nanoparticle-Mediated Delivery Product Offerings
Table 50. Cristal Therapeutics Nanoparticle-Mediated Delivery Revenue (US$, Mn), (2017-2022)
Table 51. EnColl Corporate Summary
Table 52. EnColl Nanoparticle-Mediated Delivery Product Offerings
Table 53. EnColl Nanoparticle-Mediated Delivery Revenue (US$, Mn), (2017-2022)
Table 54. Lena Nanoceutics Ltd. Corporate Summary
Table 55. Lena Nanoceutics Ltd. Nanoparticle-Mediated Delivery Product Offerings
Table 56. Lena Nanoceutics Ltd. Nanoparticle-Mediated Delivery Revenue (US$, Mn), (2017-2022)
Table 57. EyePoint Pharmaceuticals Corporate Summary
Table 58. EyePoint Pharmaceuticals Nanoparticle-Mediated Delivery Product Offerings
Table 59. EyePoint Pharmaceuticals Nanoparticle-Mediated Delivery Revenue (US$, Mn), (2017-2022)
Table 60. Nanobiotix Corporate Summary
Table 61. Nanobiotix Nanoparticle-Mediated Delivery Product Offerings
Table 62. Nanobiotix Nanoparticle-Mediated Delivery Revenue (US$, Mn), (2017-2022)
Table 63. NanoCarrier Corporate Summary
Table 64. NanoCarrier Nanoparticle-Mediated Delivery Product Offerings
Table 65. NanoCarrier Nanoparticle-Mediated Delivery Revenue (US$, Mn), (2017-2022)
Table 66. Nanospectra Corporate Summary
Table 67. Nanospectra Nanoparticle-Mediated Delivery Product Offerings
Table 68. Nanospectra Nanoparticle-Mediated Delivery Revenue (US$, Mn), (2017-2022)
Table 69. NanOlogy Corporate Summary
Table 70. NanOlogy Nanoparticle-Mediated Delivery Product Offerings
Table 71. NanOlogy Nanoparticle-Mediated Delivery Revenue (US$, Mn), (2017-2022)
Table 72. Selecta Biosciences Corporate Summary
Table 73. Selecta Biosciences Nanoparticle-Mediated Delivery Product Offerings
Table 74. Selecta Biosciences Nanoparticle-Mediated Delivery Revenue (US$, Mn), (2017-2022)
Table 75. Parvus Therapeutics Corporate Summary
Table 76. Parvus Therapeutics Nanoparticle-Mediated Delivery Product Offerings
Table 77. Parvus Therapeutics Nanoparticle-Mediated Delivery Revenue (US$, Mn), (2017-2022)
Table 78. Starpharma Corporate Summary
Table 79. Starpharma Nanoparticle-Mediated Delivery Product Offerings
Table 80. Starpharma Nanoparticle-Mediated Delivery Revenue (US$, Mn), (2017-2022)
Table 81. Tarveda Therapeutics Corporate Summary
Table 82. Tarveda Therapeutics Nanoparticle-Mediated Delivery Product Offerings
Table 83. Tarveda Therapeutics Nanoparticle-Mediated Delivery Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Nanoparticle-Mediated Delivery Segment by Type in 2021
Figure 2. Nanoparticle-Mediated Delivery Segment by Application in 2021
Figure 3. Global Nanoparticle-Mediated Delivery Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Nanoparticle-Mediated Delivery Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Nanoparticle-Mediated Delivery Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Nanoparticle-Mediated Delivery Revenue in 2021
Figure 8. By Type - Global Nanoparticle-Mediated Delivery Revenue Market Share, 2017-2028
Figure 9. By Application - Global Nanoparticle-Mediated Delivery Revenue Market Share, 2017-2028
Figure 10. By Region - Global Nanoparticle-Mediated Delivery Revenue Market Share, 2017-2028
Figure 11. By Country - North America Nanoparticle-Mediated Delivery Revenue Market Share, 2017-2028
Figure 12. US Nanoparticle-Mediated Delivery Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Nanoparticle-Mediated Delivery Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Nanoparticle-Mediated Delivery Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Nanoparticle-Mediated Delivery Revenue Market Share, 2017-2028
Figure 16. Germany Nanoparticle-Mediated Delivery Revenue, (US$, Mn), 2017-2028
Figure 17. France Nanoparticle-Mediated Delivery Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Nanoparticle-Mediated Delivery Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Nanoparticle-Mediated Delivery Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Nanoparticle-Mediated Delivery Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Nanoparticle-Mediated Delivery Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Nanoparticle-Mediated Delivery Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Nanoparticle-Mediated Delivery Revenue Market Share, 2017-2028
Figure 24. China Nanoparticle-Mediated Delivery Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Nanoparticle-Mediated Delivery Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Nanoparticle-Mediated Delivery Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Nanoparticle-Mediated Delivery Revenue, (US$, Mn), 2017-2028
Figure 28. India Nanoparticle-Mediated Delivery Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Nanoparticle-Mediated Delivery Revenue Market Share, 2017-2028
Figure 30. Brazil Nanoparticle-Mediated Delivery Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Nanoparticle-Mediated Delivery Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Nanoparticle-Mediated Delivery Revenue Market Share, 2017-2028
Figure 33. Turkey Nanoparticle-Mediated Delivery Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Nanoparticle-Mediated Delivery Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Nanoparticle-Mediated Delivery Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Nanoparticle-Mediated Delivery Revenue, (US$, Mn), 2017-2028
Figure 37. AbbVie Nanoparticle-Mediated Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. BlueWillow Biologics Nanoparticle-Mediated Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. NovaSOL Nanoparticle-Mediated Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Camurus Nanoparticle-Mediated Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Ceramisphere Nanoparticle-Mediated Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Celgene, CytImmune Nanoparticle-Mediated Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Cristal Therapeutics Nanoparticle-Mediated Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. EnColl Nanoparticle-Mediated Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Lena Nanoceutics Ltd. Nanoparticle-Mediated Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. EyePoint Pharmaceuticals Nanoparticle-Mediated Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Nanobiotix Nanoparticle-Mediated Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. NanoCarrier Nanoparticle-Mediated Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Nanospectra Nanoparticle-Mediated Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. NanOlogy Nanoparticle-Mediated Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Selecta Biosciences Nanoparticle-Mediated Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Parvus Therapeutics Nanoparticle-Mediated Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Starpharma Nanoparticle-Mediated Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Tarveda Therapeutics Nanoparticle-Mediated Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)